Powered by

Lilly Announces Upcoming Presentation of New Data Indicating Rise in Opioid Use for Migraine Treatment

Jul 10, 2019 - PR Newswire

PR Newswire

 Eli Lilly and Company (NYSE: LLY) today announced the upcoming presentation of data indicating rising rates of opioid use for the treatment of migraine based on results from the OVERCOME (Observational Survey of theEpidemiology, Treatment andCare ofMigraine) study.1 These findings will be presented on Saturday, July 13, 2019, at the 61st Annual Scientific Meeting of the American Headache Society taking place in Philadelphia.

Despite opioids typically being reserved for...